These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22389338)

  • 1. Cost effectiveness of strategies to combat chronic obstructive pulmonary disease and asthma in sub-Saharan Africa and South East Asia: mathematical modelling study.
    Stanciole AE; Ortegón M; Chisholm D; Lauer JA
    BMJ; 2012 Mar; 344():e608. PubMed ID: 22389338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study.
    Ortegón M; Lim S; Chisholm D; Mendis S
    BMJ; 2012 Mar; 344():e607. PubMed ID: 22389337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study.
    Ginsberg GM; Lauer JA; Zelle S; Baeten S; Baltussen R
    BMJ; 2012 Mar; 344():e614. PubMed ID: 22389347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of strategies to combat neuropsychiatric conditions in sub-Saharan Africa and South East Asia: mathematical modelling study.
    Chisholm D; Saxena S
    BMJ; 2012 Mar; 344():e609. PubMed ID: 22389339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries.
    Hogan DR; Baltussen R; Hayashi C; Lauer JA; Salomon JA
    BMJ; 2005 Dec; 331(7530):1431-7. PubMed ID: 16282380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of strategies to combat road traffic injuries in sub-Saharan Africa and South East Asia: mathematical modelling study.
    Chisholm D; Naci H; Hyder AA; Tran NT; Peden M
    BMJ; 2012 Mar; 344():e612. PubMed ID: 22389340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of strategies to combat vision and hearing loss in sub-Saharan Africa and South East Asia: mathematical modelling study.
    Baltussen R; Smith A
    BMJ; 2012 Mar; 344():e615. PubMed ID: 22389341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness analysis of strategies for tuberculosis control in developing countries.
    Baltussen R; Floyd K; Dye C
    BMJ; 2005 Dec; 331(7529):1364. PubMed ID: 16282379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness analysis of strategies for maternal and neonatal health in developing countries.
    Adam T; Lim SS; Mehta S; Bhutta ZA; Fogstad H; Mathai M; Zupan J; Darmstadt GL
    BMJ; 2005 Nov; 331(7525):1107. PubMed ID: 16282407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of malaria control in sub-Saharan Africa.
    Goodman CA; Coleman PG; Mills AJ
    Lancet; 1999 Jul; 354(9176):378-85. PubMed ID: 10437867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
    Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
    Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.
    Eaton JW; Menzies NA; Stover J; Cambiano V; Chindelevitch L; Cori A; Hontelez JA; Humair S; Kerr CC; Klein DJ; Mishra S; Mitchell KM; Nichols BE; Vickerman P; Bakker R; Bärnighausen T; Bershteyn A; Bloom DE; Boily MC; Chang ST; Cohen T; Dodd PJ; Fraser C; Gopalappa C; Lundgren J; Martin NK; Mikkelsen E; Mountain E; Pham QD; Pickles M; Phillips A; Platt L; Pretorius C; Prudden HJ; Salomon JA; van de Vijver DA; de Vlas SJ; Wagner BG; White RG; Wilson DP; Zhang L; Blandford J; Meyer-Rath G; Remme M; Revill P; Sangrujee N; Terris-Prestholt F; Doherty M; Shaffer N; Easterbrook PJ; Hirnschall G; Hallett TB
    Lancet Glob Health; 2014 Jan; 2(1):e23-34. PubMed ID: 25104632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
    Fernandes S; Sicuri E; Kayentao K; van Eijk AM; Hill J; Webster J; Were V; Akazili J; Madanitsa M; ter Kuile FO; Hanson K
    Lancet Glob Health; 2015 Mar; 3(3):e143-53. PubMed ID: 25701992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
    Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
    Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of screening and correcting refractive errors in school children in Africa, Asia, America and Europe.
    Baltussen R; Naus J; Limburg H
    Health Policy; 2009 Feb; 89(2):201-15. PubMed ID: 18621429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis.
    Kuznik A; Habib AG; Munube D; Lamorde M
    BMC Health Serv Res; 2016 Jul; 16():304. PubMed ID: 27461265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Interventions to Improve Maternal, Newborn and Child Health Outcomes: A WHO-CHOICE Analysis for Eastern Sub-Saharan Africa and South-East Asia.
    Stenberg K; Watts R; Bertram MY; Engesveen K; Maliqi B; Say L; Hutubessy R
    Int J Health Policy Manag; 2021 Nov; 10(11):706-723. PubMed ID: 33904699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of Population Level and Individual Level Interventions to Combat Non-communicable Disease in Eastern Sub-Saharan Africa and South East Asia: A WHO-CHOICE Analysis.
    Bertram MY; Chisholm D; Watts R; Waqanivalu T; Prasad V; Varghese C
    Int J Health Policy Manag; 2021 Nov; 10(11):724-733. PubMed ID: 34273918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
    Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
    Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.